Brief: Aprogen Biologics To Conduct Capital Increase Of 117 Billion Won For Operational Funds
12/01/2024 07:59
Aprogen Biologics Inc 003060.KS :
* APROGEN BIOLOGICS: TO CONDUCT CAPITAL INCREASE OF 117
BILLION
WON FOR OPERATIONAL FUNDS
Source text for Eikon: ID:
Further company coverage: 003060.KS
Recent news on Aprogen Biologics
See all newsBrief: Aprogen Biologics To Conduct Capital Increase Of 117 Billion Won For Operational Funds
Brief: Aprogen Pharmaceuticals To Lend 125 Billion Won To Affiliate Aprogen Biologics To Secure Biosimilar Production Facilities
Medics and volunteers try to prop up Ukraine's health system
Brief: Aprogen Kic To Acquire Shares Worth $17 Mln In Its Unit
Brief: Aprogen sells 7.69 pct stake in Aprogen pharmaceuticals